Comparison of lamotrigine to placebo in infants 1-24 months of age with partial seizures: Impact of response during open-label enrichment phase

被引：0
|
作者：
Warnock, CR
Caldwell, PT
Messenheimer, JA
机构：
[1] GlaxoSmithKline Inc, Biol Data Sci, Res Triangle Pk, NC USA
[2] GlaxoSmithKline Inc, Neurosci Clin Dev, Res Triangle Pk, NC USA
来源：
EPILEPSIA | 2005年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：204 / 204
页数：1
相关论文
共 22 条
  • [1] Safety and efficacy of lamotrigine in infants age 1-24 months with partial seizures:: Updated preliminary open-label results
    Piña-Garza, JE
    Gucuyener, K
    Warnock, CR
    Conklin, HS
    Morrison, D
    Messenheimer, JA
    EPILEPSIA, 2003, 44 : 111 - 111
  • [2] Salivary lamotrigine pharmacokinetics in infants aged 1-24 months with partial seizures
    Messenheimer, JA
    Sidhu, J
    Warnock, CK
    ANNALS OF NEUROLOGY, 2005, 58 : S123 - S123
  • [3] Safety and efficacy of lamotrigine in infants aged 1 to 24 months with partial seizures:: Updated preliminary open-label results
    Piña-Garza, JE
    Gucuyener, K
    Warnock, CR
    Conklin, HS
    Morrison, D
    Messenheimer, JA
    ANNALS OF NEUROLOGY, 2003, 54 : S113 - S113
  • [4] Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: A randomized, multicenter, open-label phase 1 study
    Manitpisitkul, Prasarn
    Shalayda, Kevin
    Todd, Mike
    Wang, Shean S.
    Ness, Seth
    Ford, Lisa
    EPILEPSIA, 2013, 54 (01) : 156 - 164
  • [5] Safety and efficacy of lamotrigine in subjects 1-24 months of age with partial seizures -: Double-blind phase results
    Piña-Garza, JE
    Levisohn, P
    Gucuyener, K
    Mikati, M
    Warnock, CR
    Messenheimer, J
    ANNALS OF NEUROLOGY, 2005, 58 : S91 - S91
  • [6] Safety and efficacy of lamotrigine in subjects 1-24 months of age with partial seizures-double-blind phase results
    Piña-Garza, JE
    Levisohn, P
    Gucuyener, K
    Turkey, A
    Mikati, M
    Lebanon, B
    Warnock, CR
    Messenheimer, J
    NEUROLOGY, 2005, 64 (06) : A117 - A117
  • [7] Preliminary population pharmacokinetics of lamotrigine adjunctive therapy in infants aged 1 to 24 months with partial seizures
    Schimschock, J
    Messenheimer, J
    Bullman, J
    Onks, D
    Caldwell, P
    Sidhu, JS
    ANNALS OF NEUROLOGY, 2002, 52 (03) : S143 - S143
  • [8] Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)
    Joel Schlessinger
    Julie S. Shepard
    Richard Gower
    John C. Su
    Charles Lynde
    Amy Cha
    William C. Ports
    Vivek Purohit
    Liza Takiya
    John L. Werth
    Chuanbo Zang
    Bonnie Vlahos
    American Journal of Clinical Dermatology, 2020, 21 : 275 - 284
  • [9] Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)
    Schlessinger, Joel
    Shepard, Julie S.
    Gower, Richard
    Su, John C.
    Lynde, Charles
    Cha, Amy
    Ports, William C.
    Purohit, Vivek
    Takiya, Liza
    Werth, John L.
    Zang, Chuanbo
    Vlahos, Bonnie
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (02) : 275 - 284
  • [10] A Multicentre, Open-Label, Phase IV Study of Perampanel as Monotherapy or First Adjunctive Therapy In Patients ≥12 Years of Age with Partial Seizures or Primary Generalised Tonic-Clonic Seizures: Study 410
    Klein, P.
    Williams, B.
    Laurenza, A.
    Patten, A.
    Malhotra, M.
    EPILEPSIA, 2018, 59 : S79 - S79
123